NCT05325515View on ClinicalTrials.gov

The Effect of Effervescent Alendronate on Bone Turnover

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

December 1, 2022

Conditions
Osteopenia or Osteoporosis
Interventions
DRUG

Conventional alendronate

Conventional alendronate 70mg weekly

DRUG

Effervescent and buffered alendronate

Effervescent and buffered alendronate 70mg weekly

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus C

All Listed Sponsors
lead

Aarhus University Hospital

OTHER

NCT05325515 - The Effect of Effervescent Alendronate on Bone Turnover | Biotech Hunter | Biotech Hunter